Inflammation

Items 331-340 of 412

per page
Set Descending Direction
  1. Pyridoxatin
    CAS  135529-30-5
    AG-CN2-0123
    AG-CN2-0123-C250250 µg
    CHF 75.00
    AG-CN2-0123-M0011 mg
    CHF 220.00
    Pyridoxatin
  2. Pyripyropene A
    CAS  147444-03-9
    AG-CN2-0106
    AG-CN2-0106-C250250 µg
    CHF 190.00
    AG-CN2-0106-M0011 mg
    CHF 560.00
    Pyripyropene A
  3. Quercetin dihydrate
    CAS  6151-25-3
    CDX-Q0027
    CDX-Q0027-G02525 g
    CHF 54.00
    CDX-Q0027-G05050 g
    CHF 88.00
    Quercetin dihydrate
  4. Quinidine (anhydrous)
    CAS  56-54-2
    CDX-Q0029
    CDX-Q0029-G01010 g
    CHF 64.00
    CDX-Q0029-G05050 g
    CHF 258.00
    Quinidine (anhydrous)
  5. Quinine hydrochloride dihydrate
    CAS  6119-47-7
    CDX-Q0014
    CDX-Q0014-G01010 g
    CHF 90.00
    CDX-Q0014-G05050 g
    CHF 361.00
    CDX-Q0014-G100100 g
    CHF 619.00
    Quinine hydrochloride dihydrate
  6. Radicicol
    CAS  12772-57-5
    AG-CN2-0021
    AG-CN2-0021-M0011 mg
    CHF 50.00
    AG-CN2-0021-M0055 mg
    CHF 200.00
    Radicicol
  7. RBP4 (human) ELISA Kit (Quantitative)
    AG-45A-0035Y
    AG-45A-0035YEK-KI0196 wells
    CHF 560.00
    AG-45A-0035YTP-KI012 x 96 wells
    CHF 990.00
    Standardcurve
  8. RELM-β (human) Matched Pair Detection Set
    AG-46A-0001
    AG-46A-0001-KI011 Set
    CHF 750.00
    Reagents for 5 x 96-well plates
    Standardcurve
  9. Repaglinide
    CAS  135062-02-1
    CDX-R0122
    CDX-R0122-M05050 mg
    CHF 68.00
    CDX-R0122-M250250 mg
    CHF 204.00
    Repaglinide
  10. Resistin (human) (rec.)
    AG-40A-0010Y
    AG-40A-0010Y-C01010 µg
    CHF 265.00
    AG-40A-0010Y-C05050 µg
    CHF 780.00
    Effect of Resistin (human) (rec.) (AG-40A-0010Y) on glucose uptake in L6 cells.  Inhibition of insulin-stimulated glucose uptake in L6 skeletal muscle cells by resistin (as expected: 1μg/ml). Rat myoblasts (L6) were cultured and differentiated into myotub

Items 331-340 of 412

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.